AdvaMed® Acquires The Medtech Conference
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that it has closed a transaction to fully own and operate The Medtech Conference, the premier global gathering of…
AdvaMed® Congratulates Alex Azar on Confirmation as HHS Secretary
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker following confirmation of Alex Azar as Secretary of the Department of…
AdvaMed® Statement on Passage of Continuing Resolution
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the passage of the current continuing resolution, which includes a…
Report Shows Life Sciences Industry Alliance is Taking Action to Curb Antimicrobial Resistance, With More to Come
GENEVA, SWITZERLAND – On January 18, the AMR Industry Alliance launched its first report that shows the commitment of the life sciences industry to tackle the public health threat of…
AdvaMed® Statement on House Proposed Continuing Resolution
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the proposed continuing resolution in the U.S. House:
AdvaMed® Applauds CMS Clarification Regarding Coverage for Insulin Delivery Technologies
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement today on CMS guidance regarding Medicare Prescription Drug Part D coverage…